Archive | February, 2018

Sluggish Tape And Possibly An End to Celgene Woes?…Update

http://oceanadesigns.net/wp-json/oembed/1.0/embed?url=http://oceanadesigns.net/envira/bahama-blue/ Update after close 2/28/18 Tape deteriorates at last hour of trading, a familiar pattern: IBB down 1.83%, QQQ down 0.64%, XBI down 1.88% for day. Biotechs still up YTD with XBI;FBT down 2.35% but still up 8.28% YTD. Celgene, Inc (CELG) sell-off continues down 9% to $87.12 on 27.87M share volume! Hard to find biotech […]

Continue Reading 0

Large Cap Biopharmaceuticals Performance Update 2018: Part 2

http://lizhingley.com/work/shanghai Large Cap Biopharmaceuticals: Winners and Losers, Takeaways Here is a brief analysis from data below. Data Sources : Google Finance and FinViz.com. Our Top Picks continue to do well: Abbvie (ABBV), Bristol-Myers Squibb (BMY) and Gilead Sciences (GILD). Laggards in our focus group are Biogen (BIIB) and Celgene (CELG).Both lack drivers and revenue or EPS growth. […]

Continue Reading 0

Rayno BioBeat 2018 #2: Biotech Deal Sparks Rally…Update-1

http://brash3d.com/arq_03/ Update-1 …2/17/18 Good Week for Biotech: FBT up 6.29%, IBB up 4.44%, XBI up 6.26% Biotech stocks continued their strong recovery from the big sell-off in the prior week but about 3% under 2018 highs. Biotech ETFs tracked the QQQ up 5.68% for the week but biotech stocks are leaders YTD beating the S&P 500. […]

Continue Reading 0

Large Cap Biopharma Performance Update 2018-Part 1

Large Cap Biopharmaceuticals Performance Part 1- After Correction Technicals: we are holding the December 2017 bottom but 2018 gains on some indices have been wiped out with peak values on Jan. 26. The FBT was the top performing ETF in 2018 YTD. Many of our picks have outperformed the market. Here are some metrics on […]

Continue Reading 0

How Bad Was The Biotech Selloff Last Week?…Updates-2/6

Updates-2… 2/6/18 Biotechs Down With Overall Market Over 5 Days  Closing Prices as of 2/6/18 XBI up 3% at $91.05 down 5.34% over 5 days IBB up 2% at $109.36 down 7.35% over 5 days QQQ up 2.65% at $162.31 down 5.04% over 5 days By now you have read about all the possible reasons […]

Continue Reading 0

What’s Next After Profit Taking Hits Biotech and Drug Stocks?

Profit Taking Hits Biotech Stocks Disruption Coming to Healthcare? Another Round of Sector Rotation? The biotech sector hit a wall after breaking through to new highs last week. The major news that sparked profit taking on Tuesday was that Amazon, Berkshire Hathaway and J.P.Morgan formed a consortium to address rising healthcare costs by trying to […]

Continue Reading 0